60 Degrees Pharmaceuticals, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SXTP research report →
Companywww.60degreespharma.com
60 Degrees Pharmaceuticals, Inc. , a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria preventative treatment.
- CEO
- Geoffrey Stuart Dow
- IPO
- 2023
- Employees
- 3
- HQ
- Washington, DC, US
Price Chart
Valuation
- Market Cap
- $1.13M
- P/E
- -0.32
- P/S
- 1.12
- P/B
- 0.50
- EV/EBITDA
- 0.27
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 20.90%
- Op Margin
- -791.09%
- Net Margin
- -755.16%
- ROE
- -200.17%
- ROIC
- -162.21%
Growth & Income
- Revenue
- $1.01M · 65.49%
- Net Income
- $-7,368,325 · 7.28%
- EPS
- $-11.73 · 84.19%
- Op Income
- $-7,758,579
- FCF YoY
- -21.24%
Performance & Tape
- 52W High
- $14.68
- 52W Low
- $1.29
- 50D MA
- $1.78
- 200D MA
- $3.76
- Beta
- 2.70
- Avg Volume
- 1.19M
Get TickerSpark's AI analysis on SXTP
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 13, 26 | Francois Eric | other | 0 |
| Dec 15, 25 | DOW GEOFFREY S | buy | 9,670 |
| Dec 11, 25 | DOW GEOFFREY S | buy | 3,613 |
| Dec 10, 25 | DOW GEOFFREY S | buy | 9,350 |
| Sep 12, 25 | DOW GEOFFREY S | other | 7,201 |
| Sep 26, 24 | Landon Kristen | other | 4,167 |
| Jan 17, 25 | Landon Kristen | other | 4,540 |
| Feb 12, 24 | Landon Kristen | other | 0 |
| Jun 9, 25 | DOW GEOFFREY S | other | 4,376 |
| Jun 3, 25 | XU CHERYL | buy | 2,000 |
Our SXTP Coverage
We haven't published any research on SXTP yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SXTP Report →